Alkermes PLC (ALKS)
28.79
-0.45
(-1.54%)
USD |
NASDAQ |
Nov 14, 12:51
Alkermes Debt to Equity Ratio: 0.2235 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.2235 |
June 30, 2024 | 0.2254 |
March 31, 2024 | 0.2312 |
December 31, 2023 | 0.2417 |
September 30, 2023 | 0.2149 |
June 30, 2023 | 0.228 |
March 31, 2023 | 0.291 |
December 31, 2022 | 0.281 |
September 30, 2022 | 0.2818 |
June 30, 2022 | 0.2721 |
March 31, 2022 | 0.2745 |
December 31, 2021 | 0.2659 |
September 30, 2021 | 0.2704 |
June 30, 2021 | 0.2706 |
March 31, 2021 | 0.2832 |
December 31, 2020 | 0.2577 |
September 30, 2020 | 0.2541 |
June 30, 2020 | 0.26 |
March 31, 2020 | 0.2602 |
December 31, 2019 | 0.2553 |
September 30, 2019 | 0.26 |
June 30, 2019 | 0.255 |
March 31, 2019 | 0.2529 |
December 31, 2018 | 0.2385 |
September 30, 2018 | 0.2432 |
Date | Value |
---|---|
June 30, 2018 | 0.2421 |
March 31, 2018 | 0.243 |
December 31, 2017 | 0.234 |
September 30, 2017 | 0.2375 |
June 30, 2017 | 0.2351 |
March 31, 2017 | 0.2327 |
December 31, 2016 | 0.2345 |
September 30, 2016 | 0.2361 |
June 30, 2016 | 0.2791 |
March 31, 2016 | 0.2755 |
December 31, 2015 | 0.2663 |
September 30, 2015 | 0.2584 |
June 30, 2015 | 0.2536 |
March 31, 2015 | 0.2509 |
December 31, 2014 | 0.2547 |
September 30, 2014 | 0.2696 |
June 30, 2014 | 0.2671 |
March 31, 2014 | 0.2708 |
September 30, 2013 | 0.3598 |
June 30, 2013 | 0.3742 |
March 31, 2013 | 0.3875 |
December 31, 2012 | 0.4012 |
September 30, 2012 | 0.4187 |
June 30, 2012 | 0.5033 |
March 31, 2012 | 0.5205 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2149
Minimum
Sep 2023
0.291
Maximum
Mar 2023
0.2571
Average
0.2601
Median
Debt to Equity Ratio Benchmarks
Jazz Pharmaceuticals PLC | 1.465 |
Medtronic PLC | 0.5801 |
Perrigo Co PLC | 1.041 |
Iterum Therapeutics PLC | -- |
Mallinckrodt PLC | 1.693 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 2.155B |
Total Liabilities (Quarterly) | 863.18M |
Shareholders Equity (Quarterly) | 1.292B |
Current Ratio | 3.448 |
Net Debt Paydown Yield | 0.01% |